摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(3aS,4S,7aR)-ethyl 4-methyl-3,3a,4,7a-tetrahydro-2H-furo[2,3-b]pyran-6-carboxylate

中文名称
——
中文别名
——
英文名称
(3aS,4S,7aR)-ethyl 4-methyl-3,3a,4,7a-tetrahydro-2H-furo[2,3-b]pyran-6-carboxylate
英文别名
4-methyl-2,3,3a,7a-tetrahydro-4H-furo[2,3-b]pyran-6-carboxylic acid ethyl ester;ethyl (3aS,4S,7aR)-4-methyl-3,3a,4,7a-tetrahydro-2H-furo[2,3-b]pyran-6-carboxylate
(3aS,4S,7aR)-ethyl 4-methyl-3,3a,4,7a-tetrahydro-2H-furo[2,3-b]pyran-6-carboxylate化学式
CAS
——
化学式
C11H16O4
mdl
——
分子量
212.246
InChiKey
RCGXPWCLSICOBG-DKCNOQQISA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2
  • 重原子数:
    15
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.73
  • 拓扑面积:
    44.8
  • 氢给体数:
    0
  • 氢受体数:
    4

反应信息

  • 作为产物:
    描述:
    2,3-二氢呋喃(E)-ethyl 2-oxo-3-pentenoate 在 copper(2,2'-isopropylidenebis[(4S)-4-tert-butyl-2-oxazoline])(triflate)2 作用下, 以 四氢呋喃 为溶剂, 反应 48.0h, 以51%的产率得到(3aS,4S,7aR)-ethyl 4-methyl-3,3a,4,7a-tetrahydro-2H-furo[2,3-b]pyran-6-carboxylate
    参考文献:
    名称:
    一种新颖的催化和高对映选择性的方法,用于合成旋光碳水化合物衍生物。
    摘要:
    提出了α,β-不饱和羰基化合物与手性双恶唑啉与Cu(OTf)2结合作为路易斯酸催化的富电子烯烃的催化对映选择性逆电子需求异狄尔斯-阿尔德反应。γ-取代的β,γ-不饱和α-酮酯与乙烯基醚和各种类型的顺式-二取代的烯烃的反应以良好的收率,高的非对映选择性和优异的对映选择性进行。该反应的潜力通过合成旋光碳水化合物如螺糖,β-D-甘露糖苷乙基四乙酸酯和乙缩醛保护的C-2-支链碳水化合物来证明。根据X射线晶体学数据和产物的绝对构型,建议烯烃接近反应α的si面,
    DOI:
    10.1021/jo9918596
点击查看最新优质反应信息

文献信息

  • Asymmetric Cycloaddition of β,γ-Unsaturated α-Ketoesters with Electron-Rich Alkenes Catalyzed by a Chiral Er(OTf)3/N,N′-Dioxide Complex: Highly Enantioselective Synthesis of 3,4-Dihydro-2 H-pyrans
    作者:Yin Zhu、Mingsheng Xie、Shunxi Dong、Xiaohu Zhao、Lili Lin、Xiaohua Liu、Xiaoming Feng
    DOI:10.1002/chem.201100520
    日期:2011.7.11
    The asymmetric inverse‐electron‐demand hetero‐Diels–Alder (HDA) reactions of β,γ‐unsaturated α‐ketoesters with electron‐rich alkenes were investigated, with an N,N′‐dioxide/erbium(III) complex employed as the catalyst. Quantitative conversion of the β,γ‐unsaturated α‐ketoesters and excellent enantioselectivities (up to >99 % ee) and diastereoselectivities (up to >99:1 d.r.) were observed for a broad
    研究了β,γ-不饱和α-酮酸酯与富电子烯烃的不对称逆电子需求杂Diels-Alder(HDA)反应,并使用N,N'-二氧化物/ er(III)络合物作为催化剂。通过使用0.5–0.05 mol%的底物,在各种底物上都观察到了β,γ-不饱和α-酮酸酯的定量转化以及出色的对映选择性(高达> 99%  ee)和非对映选择性(高达> 99:1 dr)。在温和的反应条件下负载催化剂。可以将反应放大到克级,得到相同的结果。此外,这是Er(OTf)3的首次应用不对称逆电子需求的HDA反应,它表现为一种有效的催化剂。此外,通过合成某些天然产物的关键中间体,证明了该方法的合成效用。
  • Highly Enantioselective Catalytic Hetero-Diels-Alder Reaction with Inverse Electron Demand
    作者:Jacob Thorhauge、Mogens Johannsen、Karl Anker Jørgensen
    DOI:10.1002/(sici)1521-3773(19980918)37:17<2404::aid-anie2404>3.0.co;2-d
    日期:1998.9.18
    Valuable substrates for the synthesis of natural products, compounds 3 (R1 =alkyl, aryl, alkoxy; R2 , R3 =alkyl) are formed from β,γ-unsaturated α-keto esters 1 and vinyl ethers 2 by the title reaction [Eq. (1)]. Copper(II) bisoxazolines act as catalysts, and in many cases enantiomeric excesses higher than 99.5 % are achieved.
查看更多

同类化合物

马桑宁内酯 薁并[6,5-b]呋喃-2,4-二酮,十氢-5-(3-羟基丙氧基)-3a,4a-二甲基- 苦毒浆果[木防已属] 苦亭 艾瑞布林中间体 艾瑞布林 甲磺酸艾日布林 木防己苦毒宁 呋喃并[4,3,2-ij][2]苯并吡喃-2,7-二酮,2a,3,4,6,8a,8b-六氢-6-甲基-5-[(1S)-1,3,3-三甲基环己基]-,(2aR,6R,8aS,8bR)- 全内酯 二氢苦毒宁 6-甲基-4-氧代-4H-呋喃并[3,2-c]吡喃-3-甲酰氯 6-(4-羟基苯基)-2,3,3-三甲基-2H-呋喃并[5,4-b]吡喃-4-酮 4H-呋喃并[2,3-c]吡喃基莫匹罗星钠 3-甲基2H-呋喃并[2,3-c]吡喃-2-酮 3,5-二甲基2H-呋喃并[2,3-c]吡喃-2-酮 2H-呋喃并[2,3-c]吡喃-2-酮 2-[(1E,3E)-己-1,3-二烯基]-2,6-二甲基-5,6-二氢呋喃并[5,4-b]吡喃-3,4-二酮 (3aS,5S,6R,9E,14R,15R,15aR)-2,3,3a,4,5,6,7,8,11,12,13,14,15,15alpha-十四氢-6,10,14-三甲基-3-亚甲基-2-氧代-5,15-环氧环十四烷并[b]呋喃-6-醇乙酸酯 (3aR,4S,7aR)-4-羟基-3,3a,4,7a-四氢呋喃并[5,4-b]吡喃-2-酮 (3aα,3bβ,6aβ,7aα)-(+/-)-hexahydro-6-hydroxy-3a-(phenylmethyl)difuro<2,3-b:3',4'-d>furan-2(3H)-one (2R,3aS,4S,6S,7aR)-3a-benzyloxy-6-ethynyl-2-methoxy-4-p-methoxybenzyloxyhexahydrofuro[2,3-b]pyran (1R,2S,6S,7S)-5,6-Dimethoxy-8-oxo-3,9-dioxa-tricyclo[5.2.2.02,6]undeca-4,10-diene-10-carboxylic acid methyl ester N3,5'-Cyclo-2',3'-O-isopropyliden-8-oxyguanosin (3aR,4aR,7aS,8aS)-2-Thioxo-hexahydro-furo[3',4':4,5]benzo[1,2-d][1,3]dioxol-5-one 9-(3',5'-O-Isopropyliden-2-keto-β-D-xylofuranosyl)-adenin (1aR,1bS,4aS,5aS)-1a-Isopropyl-hexahydro-1,4-dioxa-cyclopropa[a]pentalen-3-one [(3aR,4S,6R,7S,7aR)-7-acetyloxy-2-oxo-4-phenylsulfanyl-3,3a,4,6,7,7a-hexahydropyrano[3,4-d][1,3]oxazol-6-yl]methyl acetate (2R,3R,3aS,6R,7R,7aR)-7-azido-6-methoxy-2-phenylsulfanyl-hexahydrofuro[3,2-b]pyran-3-ol 7-Dihydroxymethyl-O1,O2-isopropyliden-3,7-anhydro-6-desoxy-D-glucofuranose (1S,2S,6S,7R)-5,6-Dimethoxy-8-oxo-3,9-dioxa-tricyclo[5.2.2.02,6]undeca-4,10-diene-10-carboxylic acid methyl ester (2R,3S)-2-Methyl-4-oxo-oxetane-3-carboxylic acid (1R,5S)-6-methylene-3-oxo-bicyclo[3.2.1]oct-1-ylmethyl ester 3-C-(3,4,6-tri-O-acetyl-2-deoxy-2-tetrachlorophthalimido-β-D-glucopyranosyl)-1-propene (2R,4aR,5aS,8aS,9S,9aR)-5a-methoxy-7-oxo-2-phenyloctahydrofuro[2',3':5,6]pyrano[3,2-d][1,3]dioxin-9-yl acetate (4R,5E,7R,9S,10S,11E,14S)-9-((benzyloxy)methoxy)-4,10-bis((tert-butyldimethylsilyl)oxy)-7-(dimethoxymethyl)-14-(furan-3-yl)-6,12-dimethyloxacyclotetradeca-5,11-dien-2-one 3-Furan-3-yl-8-methyl-5-(4,5,6,7-tetrahydro-isobenzofuran-4-yl)-2,7-dioxa-bicyclo[3.2.1]octane methyl 2,3"-anhydro-4,6-O-benzylidene-3-C-[2,2-dihydroxyethyl]-α-D-glucopyranoside (3aR,5S,6S,7aR)-5-((R)-but-3-en-2-yl)-6-hydroxyhexahydro-2H-furo[3,2-b]pyran-2-one 7-(3-Furan-3-yl-8-methyl-2,7-dioxa-bicyclo[3.2.1]oct-5-yl)-1,3,4,5,6,7-hexahydro-isobenzofuran-1-ol